SELECT PUBLICATIONS
André T et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon
cancer. N Engl J Med 2004;350(23):2343-51. Abstract
De Gramont A et al. Oxaliplatin/5FU/LV in the adjuvant treatment of Stage II and
Stage III colon cancer: Efficacy results with a median follow-up of 4 years. Proc ASCO
2005;Abstract 3501.
Hochster HS et al. Safety and efficacy of bevacizumab (Bev) when added to oxaliplatin/
fluoropyrimidine (O/F) regimens as first-line treatment of metastatic colorectal cancer
(mCRC): TREE 1 & 2 Studies. Proc ASCO 2005;Abstract 3515.
Hochster H et al. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin
as first-line therapy for patients with colorectal cancer. J Clin Oncol 2003;21(14):2703-7.
Abstract
Twelves C et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J
Med 2005;352(26):2696-704. Abstract
Wolmark N et al. A phase III trial comparing FULV to FULV + oxaliplatin in stage II or
III carcinoma of the colon: Results of NSABP protocol C-07. Proc ASCO
2005;Abstract 3500.
